SenseTime Successfully Listed on HKEX | Chenkun Family

2021-12-30

On December 30, 2021, "SenseTime," a portfolio company directly invested in by Yuanhe BingSheng Fund—managed by Yuanhe Chukun—successfully listed on the Hong Kong Stock Exchange under the stock code 0020.HK.

Dizhe Pharmaceutical Successfully Lists on the STAR Market | Chenkun Family

2021-12-10

On December 10, 2021, "Dizhe Pharmaceutical," a portfolio company of a sub-fund backed by the mother fund managed by Yuanhe Chenkun—Lilly Asia Ventures—successfully listed on the STAR Market, with stock code: 688192.

Auhua Endoscopy Successfully Lists on the STAR Market | Chenkun Family

2021-11-15

On November 15, 2021, "Auhua Endoscopy," a portfolio company invested in by Qiming Venture Partners—a sub-fund backed by the mother fund managed by Yuanhe Chenkun—successfully listed on the STAR Market, with stock code: 688212.

Weitai Medical Successfully Listed on the Hong Kong Stock Exchange | Chenkun Family

2021-10-19

On October 19, 2021, "Weitai Medical," a portfolio company backed by sub-funds invested in by the flagship fund managed by Yuanhe Chenchun Capital—including ChenDe Capital, Eli Lilly Asia Fund, and Qiming Venture Partners—successfully listed on the Hong Kong stock exchange under the stock code 2235.HK.

Zhenhua New Material Successfully Lists on the STAR Market | Chenkun Family

2021-09-14

On September 14, 2021, Zhenhua New Material, an investee company of Qingyu Fund—a sub-fund backed by the mother fund managed by Yuanhe Chencun, successfully listed on the STAR Market, with stock code: 688707.

Hongwei Technology Successfully Listed on the STAR Market | Chenkun Family

2021-09-01

On September 1, 2021, "Hongwei Technology," an investee company of Qiancheng Capital—the sub-fund backed by the mother fund managed by Yuanhe Chenchun Capital—successfully listed on the STAR Market, with stock code: 688711.